SCHEMBL292189

SCHEMBL292189

COc1ccccc1N1CC(C)(C)NCC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
POLB P06746 1/20 0.48
ATM Q13315 3/20 0.45
MGLL Q99685 1/20 0.43
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
ADRB1 P08588 1/20 0.41
DRD2 P14416 1/20 0.41
CYP2C19 P33261 1/20 0.41
DRD3 P35462 1/20 0.41
HTR3A P46098 1/20 0.41
HTR6 P50406 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292445 0.85 REN (0.38) ALDH1A1POLBATMADRA1DADRA1A
SCHEMBL292591 0.84 REN (0.39) ALDH1A1POLBADRA1DADRA1AADRA1B
SCHEMBL292191 0.84 HTR3E (0.46) ALDH1A1POLBADRA1DADRA1AADRA1B
SCHEMBL292789 0.83 REN (0.40) ALDH1A1POLBADRA1DADRA1AADRA1B
SCHEMBL294226 0.81 DDB1 (0.49) ALDH1A1MGLLMAPTKDM4EKMT2A
SCHEMBL292679 0.79 HSD11B1 (0.46) ALDH1A1MGLLMAPTKDM4ESMN1; SMN2
SCHEMBL291891 0.79 LMNA (0.47) ALDH1A1MGLLMAPTKMT2AMEN1
SCHEMBL292960 0.79 MEN1 (0.53) ALDH1A1MGLLKMT2AMEN1SMN1; SMN2
SCHEMBL291894 0.77 MAPT (0.43) ALDH1A1POLBADRA1DMAPTKDM4E
SCHEMBL292701 0.76 AR (0.44) ALDH1A1MAPTKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 ALDH1A1 1293/4885POLB 2263/4885ATM 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.